The medical imaging phantom market attained a value of USD 152.28 million in 2023. The market is further expected to grow at a CAGR of 6% during the forecast period of 2024-2032 to attain a value of USD 256.62 million by 2032, likely to be driven by the rising awareness regarding diagnosis to detect disorders.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The medical imaging phantoms industry is being driven by the increasing demand for minimally invasive surgical procedures and the rising awareness regarding diagnosis to detect disorders. The demand for X-ray phantoms is on the increase in spine-associated issues owing to growing X-ray applications.
Imaging phantom, or usually phantom, is a specially constructed object that is used as stand-ins for human tissues to evaluate and further ensure that imaging systems operate correctly. The global medical imaging phantoms market can be divided based on segments like device type and end-use.
The medical imaging phantoms market can be divided based on its device-type into X-ray/fluoroscopy phantoms, ultrasound phantoms, CT phantoms, MRI phantoms, and nuclear imaging phantoms, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The medical imaging phantoms market can be broadly categorised based on its end-use into:
The EMR report looks into the regional medical imaging phantom markets like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
The growing incidences of lifestyle-related diseases, such as chronic obstructive pulmonary disease (COPD), heart failure, and chronic kidney disease (CKD), and the rising demand for early diagnostic techniques are some of the main drivers for the global medical imaging phantoms market growth. The growing numbers of diagnostic imaging equipment, rising medical expenses, and the introduction of technologically advanced products are anticipated to boost the development of the industry. It is also anticipated that increased demand for minimally invasive surgical procedures will increase the demand for sophisticated imaging phantoms that can be used to test intraoperative imaging technologies.
The technology of magnetic resonance imaging detects different problems, including nausea and headache. The increasing demand for safer imaging methods in preclinical and clinical research is anticipated to increase the use of innovative phantoms in medical imaging, thus, aiding the growth of the global medical imaging phantoms industry over the forecast period. Fluoroscopy phantoms give pictures of high quality, resulting in its increased acceptance among the consumers and influencing the growth of the market. It is anticipated that the growing incidence of illnesses such as heart failure, multiple kinds of cancer, and chronic illnesses will play a significant role in driving market growth. Advanced medical phantoms enhance early detection capacities in imaging systems, thus, driving the market growth further.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global medical imaging phantoms market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
|Scope of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type
|Breakup by End User
|Breakup by Region
|Report Price and Purchase Option
|Explore our purchase options that are best suited to your resources and industry needs.
|Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Medical Imaging Phantoms Market Overview
3.1 Global Medical Imaging Phantoms Market Historical Value (2017-2023)
3.2 Global Medical Imaging Phantoms Market Forecast Value (2024-2032)
4 Global Medical Imaging Phantoms Market Landscape
4.1 Global Medical Imaging Phantoms Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Medical Imaging Phantoms Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by End User
4.2.3 Analysis by Major Regions
5 Global Medical Imaging Phantoms Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Medical Imaging Phantoms Market Segmentation
6.1 Global Medical Imaging Phantoms Market by Type
6.1.1 Market Overview
6.1.6 Nuclear Imaging
6.2 Global Medical Imaging Phantoms Market by End User
6.2.1 Market Overview
6.2.3 Academic and Research Institutes
6.2.4 Diagnostic and Reference Laboratories
6.2.5 Medical Device Companies
6.3 Global Medical Imaging Phantoms Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Medical Imaging Phantoms Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Medical Imaging Phantoms Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Medical Imaging Phantoms Market
9.1 Market Share by Country
10 Latin America Medical Imaging Phantoms Market
10.1 Market Share by Country
11 Middle East and Africa Medical Imaging Phantoms Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Biodex, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Carville Limited
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Computerized Imaging Reference Systems, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Dielectric Manufacturing
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Gold Standard Phantoms
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Kyoto Kagaku Co., Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Modus Medical Devices Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Leeds Test Objects
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Pure Imaging Phantoms
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 PTW Freiburg GmbH
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 The Phantom Laboratory
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13 Frank Shield
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.15 Newmatic Medica
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.16 Image Owl
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.17 Imaging Solutions Pty Ltd.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.18 Cone Instruments
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
18 Global Medical Imaging Phantoms Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The global medical imaging phantoms market reached a value of USD 152.28 million in 2023.
The market is further expected to grow at a CAGR of 6% during the forecast period of 2024-2032 to attain a value of USD 256.62 million by 2032.
The major drivers of the industry include the rising disposable incomes, increasing population, rising incidences of lifestyle-related diseases, such as chronic obstructive pulmonary disease (COPD), heart failure, and chronic kidney disease (CKD), and the rising demand for early diagnostic techniques.
The rising demand for safer imaging methods in preclinical and clinical research is expected to be a key trend guiding the growth of the industry.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market.
The leading device types available in the industry are X-ray/fluoroscopy phantoms, ultrasound phantoms, CT phantoms, MRI phantoms, and nuclear imaging phantoms, among others.
The significant end use sectors in the market are hospitals, academic and research institutes, diagnostic and reference laboratories, and medical device companies.
The leading players in the market are Biodex Medical Systems, Inc., Computerized Imaging Reference Systems, Inc., Kyoto Kagaku Co., Ltd., Modus Medical Devices Inc., and Pure Imaging Phantoms.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.